Rapid CD4 Decline After Stopping Antiretroviral Therapy
Author Information
Author(s): Sungkanuparph Somnuek, Kiertiburanakul Sasisopin, Apisarnthanarak Anucha, Malathum Kumthorn, Watcharananan Siriorn, Sathapatayavongs Boonmee
Primary Institution: Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Hypothesis
Can treatment interruption in HIV patients with high CD4 counts lead to safe outcomes in resource-limited settings?
Conclusion
Stopping NNRTI-based antiretroviral therapy leads to a quick drop in CD4 counts and a high chance of needing to restart treatment.
Supporting Evidence
- Median CD4 change at 3 months after treatment interruption was -259 cells/mm3 for NNRTI and -105 cells/mm3 for PI.
- 51% of patients in the NNRTI group resumed ART compared to 36% in the PI group.
- Median time to resume ART was 5.5 months for NNRTI and 14.2 months for PI.
Takeaway
If people with HIV stop their medicine, their health can get worse really fast, especially if they were taking a certain kind of medicine called NNRTI.
Methodology
A prospective study followed HIV-infected patients who interrupted their antiretroviral therapy, monitoring CD4 counts and HIV-related symptoms.
Potential Biases
The study's design may have introduced bias due to the specific inclusion criteria focusing on patients willing to interrupt therapy.
Limitations
The study had a small sample size and a higher proportion of patients with lipodystrophy, which may not represent the general population.
Participant Demographics
Mean age was 40.6 years, with 46% males; 83% had lipodystrophy.
Statistical Information
P-Value
p = 0.022
Confidence Interval
95%CI, 1.5–16.3
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website